NINGBO INNO PHARMCHEM CO.,LTD. specializes in providing high-quality pharmaceutical ingredients that are pivotal in modern medical procedures. Among these, Eptifibatide Powder plays a critical role in enhancing the safety and efficacy of Percutaneous Coronary Intervention (PCI) by focusing on thrombosis prevention.

PCI is a minimally invasive procedure used to open narrowed or blocked coronary arteries. Despite its advancements, there remains a significant risk of thrombotic complications, where blood clots can form within the stented artery, potentially leading to heart attack or stroke. Eptifibatide Powder, a potent platelet glycoprotein IIb/IIIa receptor antagonist, is specifically designed to mitigate this risk. As a cyclic heptapeptide, it effectively blocks the final common pathway of platelet aggregation.

The administration of Eptifibatide powder raw material during PCI is a standard practice for many interventional cardiologists. Its ability to inhibit thrombus formation is crucial in preventing perioperative thrombotic complications, ensuring a smoother recovery for patients. The drug's rapid onset and short duration of action allow for precise management of anticoagulation, a key factor in the success of complex PCI procedures.

For those involved in the supply chain or research, understanding the properties of this Eptifibatide powder is paramount. Its high purity, typically exceeding 99%, and its white powder form signify its pharmaceutical grade. The specific CAS number, 188627-80-7, is a critical identifier for this specialized chemical. The compound's effectiveness in preventing platelet aggregation makes it an indispensable tool in the interventional cardiology toolkit.

Beyond PCI, Eptifibatide's utility in managing Acute Coronary Syndrome (ACS) further highlights its importance in cardiovascular care. NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to supporting the medical community by providing access to such critical antithrombotic agents, thereby contributing to improved patient outcomes and safer medical interventions.